Valbiotis

About:

Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.

Website: http://valbiotis.com/

Twitter/X: valbiotis

Top Investors: Sofimac Investment Managers

Description:

Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. The company develops Valedia, a product that is in Phase II clinical trials for the treatment of type 2 diabetes.

Total Funding Amount:

26.5M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

La Rochelle, Poitou-Charentes, France

Founded Date:

2014-01-01

Founders:

Jocelyn Pineau, Sebastien PELTIER

Number of Employees:

11-50

Last Funding Date:

2022-11-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai